PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX22F30234557459360!gamunex-c 20 GRAM 200 ML VIAL 200ml — Amerisourcebergen Drug Corp

Amerisourcebergen Drug Corp holds $19.3B across 1,357,999 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent SPE2DX15D3501. PoP ended Jun 16, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Amerisourcebergen Drug Corp
Recipient
Jun 16, 2022
PoP end
$109K
Obligated
$109K
Potential
325411
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Amerisourcebergen Drug Corp — $90

Contract facts

Federal
Contract numberSPE2DX22F3023
Also listed asSPE2DX-22-F-3023
Also listed asSPE2DX15D3501-SPE2DX22F3023
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentAmerisourcebergen Drug Corp
CAGE1XUY5
UEIKABZK8W6PQT3
NAICS325411

No full NAICS 325411 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DX15D3501
Place of performanceCONSHOHOCKEN PA
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
PoP startMay 25, 2022
PoP end (current)Jun 16, 2022
Obligated$109K
Current value$109K
Potential value$109K

4557459360!GAMUNEX-C 20 GRAM/200 ML VIAL 200ML is a federal award for Dla Troop Support held by Amerisourcebergen Drug Corp. Estimated value $109K ($109K obligated). Current period of performance ends Jun 16, 2022. Place of performance: CONSHOHOCKEN PA.

4557459360!GAMUNEX-C 20 GRAM/200 ML VIAL 200ML

Recompete timing

Public
Past PoP end (1527 days ago)

Current PoP ended Jun 16, 2022 (1527 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Amerisourcebergen Drug Corp$19.3B obligated across 1,357,999 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($19.3B) · all agencies
Department of Defense (DOD)$19.3B · 100%Department of Health and Human Services (HHS)$7.6M · 0%Department of Veterans Affairs (VA)$5.9M · 0%Department of Justice (DOJ)$68K · 0%
Open full company profile

Related awards

Same parent · incumbent
36C77026P0121
DROSPIRENONE
$321K
Sep 27, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DX22F3023?

SPE2DX22F3023 (4557459360!gamunex-c 20 GRAM 200 ML VIAL 200ml) is a Dla Troop Support award with a potential value of $109K, currently held by Amerisourcebergen Drug Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2DX-22-F-3023?

SPE2DX-22-F-3023 is the dashed form of PIID SPE2DX22F3023 (4557459360!gamunex-c 20 GRAM 200 ML VIAL 200ml), held by Amerisourcebergen Drug Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2DX22F3023?

Dla Troop Support awarded SPE2DX22F3023 to Amerisourcebergen Drug Corp (potential $109K).

Who is the incumbent on SPE2DX22F3023?

Amerisourcebergen Drug Corp is the incumbent with $19.3B across 1357999 related awards in SCOUT’s public footprint. The current period of performance ends Jun 16, 2022.

When does Amerisourcebergen Drug Corp’s SPE2DX22F3023 come up for recompete?

SCOUT tracks a period-of-performance end of Jun 16, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DX22F3023